Pfizer Continues Its Biologics Focused Deal-Making
By Helen Scrutton
Pharma Deals Review: Vol 2008 Issue 96 (Table of Contents)
Published: 20 May-2008
DOI: 10.3833/pdr.v2008.i96.175 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Pfizer and Five Prime Therapeutics reach agreement for the discovery of antibody targets and novel therapeutic protein products to treat cancer and diabetes...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS